168 related articles for article (PubMed ID: 6843128)
1. Cutaneous signs of internal malignancies.
Helm F
J Surg Oncol; 1983 May; 23(1):1-4. PubMed ID: 6843128
[TBL] [Abstract][Full Text] [Related]
2. [Cutaneous-internal malignancy syndrome associated with specific skin lesions].
Arao T; Ohishi M; Yamada M; Nakamura T
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1581-7. PubMed ID: 3382230
[TBL] [Abstract][Full Text] [Related]
3. [Paraneoplastic skin diseases].
Khoschbin T; Löser C; Dippel E
Internist (Berl); 2019 Aug; 60(8):775-782. PubMed ID: 31273399
[TBL] [Abstract][Full Text] [Related]
4. [Paraneoplastic dermatoses].
Barrière H
Ann Med Interne (Paris); 1975 Mar; 126(3):177-81. PubMed ID: 1122088
[No Abstract] [Full Text] [Related]
5. [Skin disorders as markers of internal disease. Paraneoplastic dermatoses].
Weismann K
Ugeskr Laeger; 2000 Dec; 162(50):6834-9. PubMed ID: 11187137
[TBL] [Abstract][Full Text] [Related]
6. Skin manifestations of internal malignancy.
Braverman IM
Clin Geriatr Med; 2002 Feb; 18(1):1-19, v. PubMed ID: 11913734
[TBL] [Abstract][Full Text] [Related]
7. [Cutaneous paraneoplastic syndromes. 1].
Herzberg JJ
Fortschr Med; 1971 Sep; 89(27):1045-8. PubMed ID: 4262967
[No Abstract] [Full Text] [Related]
8. Cutaneous manifestations of malignant disease.
Higgins EM; du Vivier AW
Br J Hosp Med; 1992 Nov 4-17; 48(9):552-4, 558-61. PubMed ID: 1477711
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous signs of internal malignant disease.
Sibrack LA
Prim Care; 1978 Jun; 5(2):263-80. PubMed ID: 210475
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous manifestations of visceral malignancy.
Sneddon IB
Postgrad Med J; 1970 Nov; 46(541):678-85. PubMed ID: 4924274
[No Abstract] [Full Text] [Related]
11. [Cutaneous paraneoplastic syndromes].
Barrière H
Ann Med Interne (Paris); 1984; 135(8):662-8. PubMed ID: 6241441
[TBL] [Abstract][Full Text] [Related]
12. Skin signs of internal malignancy.
Ridgway HB
Am Fam Physician; 1978 Mar; 17(3):123-9. PubMed ID: 629192
[TBL] [Abstract][Full Text] [Related]
13. [Cutaneous paraneoplastic syndromes].
Herzberg JJ
Internist (Berl); 1973 Jan; 14(1):25-6. PubMed ID: 4576794
[No Abstract] [Full Text] [Related]
14. [Cutaneous paraneoplastic syndromes].
Wolff H
Hautarzt; 2001 Feb; 52(2):159-72; quiz 172-4. PubMed ID: 11244897
[No Abstract] [Full Text] [Related]
15. What is your diagnosis? Necrolytic migratory erythema associated with a glucagonoma.
Chaw L; Krop TM; Hood AF
Cutis; 2008 Jan; 81(1):25, 30-2. PubMed ID: 18306843
[No Abstract] [Full Text] [Related]
16. Transforming growth factor-alpha (TGF alpha)-producing gastric carcinoma with acanthosis nigricans: an endocrine effect of TGF alpha in the pathogenesis of cutaneous paraneoplastic syndrome and epithelial hyperplasia of the esophagus.
Koyama S; Ikeda K; Sato M; Shibahara K; Yuhara K; Fukutomi H; Fukunaga K; Kanazawa N; Yuzawa K; Fukao K; Iijima T; Kikuchi M; Tomiya T; Fujiwara K
J Gastroenterol; 1997 Feb; 32(1):71-7. PubMed ID: 9058298
[TBL] [Abstract][Full Text] [Related]
17. Necrolytic migratory erythema: first symptom of a glucagonoma. A case report.
Du Jardin P; Cools P; Van der Stighelen Y
Acta Chir Belg; 2004 Aug; 104(4):468-70. PubMed ID: 15469167
[TBL] [Abstract][Full Text] [Related]
18. Necrolytic Migratory Erythema: A Forgotten Paraneoplastic Condition.
Tremblay C; Marcil I
J Cutan Med Surg; 2017; 21(6):559-561. PubMed ID: 28662584
[TBL] [Abstract][Full Text] [Related]
19. Metastatic adenocarcinoma of the stomach presenting as malignant acanthosis nigricans and tripe palms: a case report.
Lam CPM; Chan MWM
Hong Kong Med J; 2023 Aug; 29(4):355-357. PubMed ID: 37489275
[No Abstract] [Full Text] [Related]
20. Necrolytic migratory erythema: a cutaneous clue to glucagonoma syndrome.
Remes-Troche JM; García-de-Acevedo B; Zuñiga-Varga J; Avila-Funes A; Orozco-Topete R
J Eur Acad Dermatol Venereol; 2004 Sep; 18(5):591-5. PubMed ID: 15324403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
